Also found in: Medical, Wikipedia.
Related to finasteride: minoxidil


A synthetic androgen inhibitor used primarily in men for the treatment of benign prostatic hyperplasia and androgenetic alopecia.

[fin- (alteration of (al)ph(a-reductase) in(hibitor)) + (az)aster(oid), steroid containing azine (alteration of azo- + steroid) + (am)ide.]


n finasterida
References in periodicals archive ?
Finasteride (Proscar[R], Propecia[R]) and dutasteride (Avodart[R]) are in a class of medications called 5-alpha reductase inhibitors because they block the effects of the enzyme and prevent the conversion of testosterone to DHT, but they don't reduce testosterone levels.
Avram said he has found that PRP is a good option for patients with difficult hair loss, such as those who had extensive hair loss after chemotherapy but the hair never grew back in the same fashion, or patients who have failed treatment with finasteride and minoxidil.
The controversial hair loss medication finasteride is said to be the secret behind US President Donald Trump's bizarre hair.
Finasteride and dutasteride, both 5-alpha reductase inhibitors, are considered first-line treatment for androgenetic hair loss in men and used increasingly in women.
Finasteride is a selective inhibitor of type-2 5-alpha reductase enzyme, preventing the conversion of testosterone to dihydrotestosterone (DHT).
Pharmaceutical company Mylan NV (NasdaqMYL) TASE:MYL) stated on Monday that it has introduced Finasteride Tablets USP, 1 mg in the US market.
In the trial, the inhibitory potency of saw palmetto supercritical CO2 extract (SPSE) was compared to that of finasteride, an approved 5[alpha]-reductase inhibitor, on the basis of the enzymatic conversion of the substrate androstenedione to the 5[alpha]-reduced product 5[alpha]-androstanedione.
Finasteride and dutasteride are approved for pattern hair loss in men, but not in women.
With respect to trials assessing androgen blockers in men to prevent prostate cancer, the Prostate Cancer Prevention Trial is assessing the use of finasteride in men aged 55years and older.
As noted, the median prostate volume in men taking finasteride was 25% lower compared to the placebo group, which represents a huge relative reduction in bulky prostate tissues.
Men who took finasteride to prevent prostate cancer as part of a randomized clinical trial that ended in 2003 had the same long-term mortality as did those who took placebo, according to a report published online in the New England Journal of Medicine.